Life sciences can’t afford not to take advantage of intelligent web
and social listening technology. It is the only way they can hope to
cut through the online noise and become truly vigilant about postmarketing
patient safety in an always-on digital world. And they
could pick up a lot of other valuable insights along the way if they
teach systems what to look for, say Christopher Rudolf, CEO of Volv
Partners and Adam Sherlock, CEO of ProductLife Group.